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ABSTRACT 
Background 
Craniopharyngiomas account for 6-10% of childhood brain tumours and are the third 
most common intracranial tumours of childhood. Despite their benign histological 
appearance, they are often associated with a poor outcome and have significant 
associated morbidity. 
Aim 
To analyse the data of children with craniopharyngiomas at Red Cross Children's 
Hospital and Groote Schuur Hospital from 1976 to 2004 with respect to age at 
presentation, presenting symptoms and preoperative and post operative endocrine 
dysfunction. 
Patients and methods 
The records of 45 children aged between 9 months and 13 years were reviewed. The 
majority of children in the study were aged between 5 and 10 years. There was a 
considerable delay in the diagnosis in most cases especially in areas outside of Cape 
Town. Pre operative tests prior to 2000 were incomplete but have improved since then. 
Twenty nine percent of our patients had a near total excision of the craniopharyngioma 
and 29% had partial excisions necessitating adjuvant radiotherapy. The endocrinological, 
neuro imaging and presenting symptoms were analysed and post operative tests were 
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reviewed. 
Where possible neuropsychiatric assessments were accessed as well in order to assess 
long term neurocognitive deficits 
Results. 
The age of presentation of craniopharyngiomas in our group of patients was much 
younger than in other studies with the largest group of affected children being 
between 5 and 10 years of age. The most common presenting symptoms in this group 
were headaches (62%) and visual disturbances (57%). 
Sixty four percent of the children had preoperative endocrine testing for pituitary 
dysfunction of which 59% were ACTH and TSH deficient and only 38% were growth 
hormone deficient. 
After surgery multiple endocrinopathies were universal with 56% of children having pan 
hypopituitarism at follow up. There was no reversal of pre existing hormone deficits after 
surgery. 
The management of craniopharyngiomas remains controversial. Twenty nine percent of 
our patients had a near total excision and 29 % had a partial excision combined with 
radiotherapy with a further 6 patients receiving intratumoral bleomycin for recurrences. 
Post operatively the majority of children were on replacement therapy but only 6 patients 
(14%) received human growth hormone or are receiving human growth hormone 
currently due to a lack of funds to provide human growth hormone for children with 
growth hormone deficiency. 
Seventy percent of the children had central diabetes insipidus post operatively reflecting 
posterior pituitary damage. 
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Our overall survival rate from 1976 to 2004 was 91 % with a mortality rate of 13%. 
Most of the deaths were attributed to recurrences of the craniopharyngioma and the 
complications ofbleomycin treatment. 
Conclusion 
Craniopharyngiomas remain tumours associated with significant morbidity. Total 
excision of the tumour remains a favourable option but the proximity of the 
craniopharyngioma to the pituitary gland and optic tracts results in devastating sequelae. 
Although the medical and surgical management of craniopharyngiomas has improved, a 
significant number of patients had endocrine sequelae. The management of 
craniopharyngiomas in an African context compares favourably 
internationally but with limited resources especially with regard to growth hormone 
replacement, a large proportion of our children are not receiving optimal treatment. 
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ABBREVIATIONS 
ACTH adrenocorticotrophin hormone 
GH growth hormone 
TSH thyroid stimulating hormone 
GnRH gonadotrophin releasing hormone 
FSH follicular stimulating hormone 
LH luteinising hormone 
D.I diabetes insipidus 
C.T computerized tomography 
M.R.I magnetic resonance imaging 
DDAVP desmopressin 
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INTRODUCTION AND LITERATURE REVIEW 
Craniopharyngioma is a parasellar and sellar tumour which constitutes 6 -
10% of all childhood brain tumours (2). They account for 80 - 90% of 
neoplasms arising in the pituitary area. 
Craniopharyngioma is the third most common intracranial tumour of 
childhood and the most common paediatric tumour in the hypothalamus and 
pituitary region. 
These tumours arise from squamous rest cells of the remnant of Rathke's 
pouch between the adenohypophysis and the neurohypophysis in the region of 
the pars tuberalis. 
The origin of craniopharyngioma is undetermined although several theories 
exist (1). 
One theory is that this tumour is another form of a midline congenital tumour 
not very different from an epidermoid cyst. Another theory suggests that they 
arise from inclusion of the dental anlage tissue. A third theory suggests that 
craniopharyngiomas, being remnants of the Rathke pouch, arise from 
squamous cell rests normally found at the junction of the pituitary stalk and 
pars distalis (1). 
The two major pathological variants are adamatinomatous and papillary 
types. 
The adamantinomatous type is so named because of it's hardness which results 
from calcification. 
This type is most common in children. The papillary type rarely has 
calcifications. 
7 
Figure 1 histological appearance of craniopharyngioma 
Large tumours push the chiasm upward and displace the hypothalamus and 
third ventricle. Downward pressure compresses the anterior lobe of the 
pituitary gland and results in posterior lobe atrophy secondary to stalk 
damage. 
The proximity to and subsequent pressure on vital structures of the brain , 
predispose the patients to many adverse sequelae depending on their location, 
size and growth potential. Despite their benign histological appearance, their 
prognosis may often be unfavourable and the optimal therapeutic approach 
remains controversial. 
The pituitary gland is made up of an anterior and posterior lobe, each with a 
distinctive function. 
The anterior pituitary produces growth hormone, thyroid stimulating 
hormone, adrenocorticotrophic hormone as well as follicular stimulating and 
luteinizing hormones whereas the posterior pituitary produces oxytocin and 
- ~· .. ~ ---~ . __ ....,__,~ ........ - -~ .... _ - - -· 
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anti diuretic hormones therefore any lesion of the pituitary will disrupt major 
hormonal pathways.(3) 
The clinical presentation of craniopharyngiomas is not much different from 
that of other suprasellar tumours. Due to the proximity of the tumour to the 
hormone producing cells of the hypothalamus and pituitary gland there is 
significant endocrine dysfunction. 
Clinical presentation of craniopharyngioma vary from dramatic symptoms of 
raised intracranial pressure with neurological disturbances such as headaches, 
vomiting and visual disturbances to manifestations of endocrine deficiency 
such as stunted growth and delayed puberty. 
At diagnosis up to 80% of children will have endocrine dysfunction. 
Growth hormone deficiency is common and occurs in 75% of children before 
the diagnosis of craniopharyngioma is made (11). 
Two large studies showed that at presentation only 15% of the children on 
questioning had endocrine complaints but 50 - 68% are found to be short 
on examination (4). 
Headaches are caused either by hydrocephalus with obstruction of CSF 
pathways at the Aqueduct of Sylvius or the Foramina of Munro or from 
stretching of the diaphragm sellae as the tumour grows. Visual deficits are 
caused by compression of the optic chiasm or other components of the optic 
apparatus such as the optic nerves by the suprasellar tumour growth. The most 
common visual disturbance is a bitemporal hemianopia (2). Such compression 
may produce optic nerve atrophy. Papilloedema resulting from raised 
intracranial pressure may also contribute to visual disturbances. 
Other symptoms include behavioural and cognitive dysfunction as well as 
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seizures and gait disturbances (2). 
Seventy percent of the tumours are located in the intrasellar and/or suprasellar 
region with only 20% being only suprasellar and 10% being purely intrasellar . 
Craniopharyngiomas can occasionally grow into the third ventricle and cause 
hydrocephalus. The arterial supply is usually from the anterior cerebral 
arteries and anterior communicating arteries or from the internal carotid 
arteries and posterior communicating arteries (1). 
A craniopharyngioma does not receive blood supply from the posterior 
circulation unless it is parasitized from the floor of the third ventricle. As these 
tumours enlarge they may elevate and infiltrate the optic chiasm as well as the 
hypothalamic region and as a result produce visual disturbances. 
Craniopharyngiomas do not undergo malignant degeneration and are usually 
well defined. They are slow growing tumours and are usually about 3 -
4 centimetres in diameter and are usually cystic and may be multilobulated(l). 
The ongoing debate on the treatment options with the least short and long term 
adverse effects poses further difficulties in establishing an effective 
management protocol. 
No primary medical therapy exists for treatment of this tumour. The initial 
surgical decision concerns the approach with the goal of surgical intervention 
being gross total tumour removal with preservation of the optic apparatus and 
pituitary stalk. 
The recent availability of high resolution magnetic resonance imaging has 
greatly improved the visualisation and radiological diagnosis of 
craniopharyngiomas. The neuroradiological diagnosis of a craniopharyngioma 
is based on the features of the lesion itself and its relation to surrounding 
structures. 
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The diagnosis of a craniopharyngioma is based on two characteristic features 
of the tumours -its cystic nature and the presence of calcification. 
Figure 2 : MRI illustration of a craniopharyngioma 
Though controversy surrounds the optimal management of 
craniopharyngiomas, most workers would recommend excision of the tumour 
as the definitive therapy. The management of these tumours is difficult and the 
approach may differ amongst different centres depending on factors such as 
experience of the medical team and the location of the tumour. 
Depending on the location of the tumour either intrasellar or suprasellar , the 
surgical approach and type of excision differs. 
If the predominant part of the tumour is intrasellar ,the transsphenoidal route 
is used. 
Pterional craniotomy is the standard approach to suprasellar lesions as it 
allows good visualisation of the optic chiasm and pituitary stalk. 
The aim of this study was to review the endocrine dysfunction in children with 
craniopharyngiomas pre operatively and post operatively in order to 
formulate a protocol for the future management of these children. 
The objectives included an evaluation of the following parameters from 
information documented in the folders: 
1. The presenting symptoms in the study patients in order to ascertain if 
the presentation was due to pituitary hormone deficiency or due to 
raised intracranial pressure. 
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2. Identify specific endocrine abnormalities present at the time of 
diagnosis. 
3. . Document treatment modalities such as surgery, radiotherapy and 
chemotherapy implemented for craniopharyngiomas. 
4. Identify endocrinopathies before and after surgery. 
5. The hormonal replacement therapies patients were receiving. 
There is no published data in South Africa on craniopharyngiomas in children 
especially with regard to pituitary hormone deficiencies which are a major 
cause of morbidity and mortality. 
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METHODS 
The medical records of 45 children aged between 9 months and 13 years (mean age 7 
years) were reviewed from 1976 to 2004. There were 24 females and 21 males who had 
presented to Red Cross Children's Hospital and Groote Schuur Hospital with a diagnosis 
of craniopharyngioma. 
The aim of this study was to investigate the presenting symptoms in our patients in order to 
ascertain if they were due to pituitary hormone deficiency or due to raised intracranial 
pressure, which endocrine abnormalities were present at the time of diagnosis, what 
treatment modalities the patients received and what post operative endocrinopathies were 
present after surgery and radiotherapy. 
A retrospective review of patients folders and case records was conducted. 
Ethics approval as well as permission from Groote Schuur Hospital and Red Cross 
Hospital medical superintendents were obtained before patient folders were retrieved. 
Because the study was a retrospective audit of folders, informed consent from the parents 
of the children with craniopharyngiomas was not obtained. 
A data capture sheet ( appendix A) was used to obtain the following information: 
1. Age at presentation. 
2. Age at diagnosis. 
3. Presenting symptoms were divided into three categories: a) symptoms related to 
raised intracranial pressure b) symptoms related to anterior pituitary hormone 
deficiencies c) symptoms related to posterior pituitary hormone deficiencies d) 
other symptoms such as seizures, developmental delay, ataxia , loss of consciousness. 
4. How the diagnosis of the craniopharyngioma was made - radiologically or 
histologically. 
5. Preoperative endocrine tests. 
6. Surgical and radiotherapy treatment modalities. 
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7. Incidence of recurrence of craniopharyngioma. 
8. Post operative endocrine tests. 
9. Hormonal therapy options. 
Current protocols at Red Cross Hospital and Groote Schuur Hospital implemented by the 
Department of Neurosurgery and Paediatric Endocrinology requires that all children with 
craniopharyngioma have pre operative and post operative evaluation of the hypothalamic 
pituitary axis unless surgical intervention is urgent. 
The results of tests conducted according to international guidelines were obtained from 
medical records at Red Cross Children's Hospital and Groote Schuur Hospital. 
Both anterior and posterior pituitary function are tested by means of : 
1) Metyrapone stimulation tests to assess the adrenocorticotrophin hormone axis. 
2) Clonidine stimulation and glucagons stimulation tests for growth hormone assays. 
3) Thyroid stimulating hormone levels and free thyroid hormone levels. 
4) Serum sodium and osmolality compared to urine osmolality. 
No formal water deprivation tests were done to confirm the diagnosis of diabetes insipidus. 
Where possible these tests were done pre and post operatively but in most cases (29 of the 
45 patients) the only pre operative assessments done were thyroid functions and 
electrolytes and serum osmolality. 
Although there is no fixed protocol, followup imaging of the brain is done at regular 
intervals based on the clinical picture and at the discretion of the paediatric and 
neurosurgical teams. All the patients are followed up at the paediatric endocrine clinic and 
are admitted for relevant endocrine tests as they are required. They are also seen at a 
combined neurosurgical, radiotherapy and paediatric endocrine clinic where neuro 
imaging is reviewed and future endocrine and surgical procedures are planned. 
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Social worker involvement as well as occupational therapy is mandatory to ensure that 
school is continued in an appropriate environment. To date followup of children in this 
study has extended well into adulthood. 
PATIENTS 
The study population comprised 45 patients with craniopharyngiomas identified at Red 
Cross Children's Hospital and Groote Schuur Hospital. 
Ages ranged between 9 months and 13 years with a mean age of 7 years. There were 24 
females and 21 males in the study. 
In most cases the diagnosis of craniopharyngioma was made based on radiological 
characteristics on CT head and magnetic resonance imaging of the brain and were 
confirmed histologically. 
Imaging details were available for 40 patients. Skull xrays were done 7 patients and CT 
head scans were done on 31 patients. MRI brain scans were done on 10 patients of which 4 
patients had had both CT head and MRI scans. 
Histological diagnosis were available for 3 patients where the histology was confirmed 
before surgery was done. 
ENDOCRINE EVALUATION 
Preoperative endocrine evaluation of the hypothalamic pituitary axis in the 22 patients 
diagnosed with craniopharyngiomas prior to 1990 was limited. 
Subsequently all children with craniopharyngiomas have a preoperative and a post 
operative evaluation of their pituitary hormone proflle. 
ANTERIOR PITUITARY TESTING 
The evaluation of growth hormone deficiency was performed by the clonidine stimulation 
test which is standard practice in the paediatric endocrine department. 
Growth hormone deficiency is defined as a peak growth hormone response of <10 ng/ml 
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following O.lmg/metre squared dose of oral clonidine(ll). 
Other stimulation tests to assess growth hormone release include the arginine stimulation 
test and the insulin hypoglycemia test but due to the inavailability of intravenous arginine 
and the dangers associated with hypoglycemia in children , these tests are not used in our 
unit. 
The adrenocorticotrophic axis was assessed by the response of ACTH and 11 deoxycortisol 
following the administration of metyrapone (30mg/kg given orally at 23h00 on the night 
before) . ACTH deficiency was defined by an ACTH response of <lOOpg/ml and 11 
deoxycortisol response of <200nmol/1. 
Thyroid hormone deficiency was defined as a low thyroid stimulating hormone level 
( TSH normal range 0.35 - 5.5 mIU /ml) with free thyroid hormone levels below the 
normal reference range ( T4 11.5-22.7pmol/l and T3 3.5- 6.5 pmol/1) Ranke M.B 
Diagnostics of endocrine function in children and adolescents. 
Gonadotrophin deficiency was difficult to assess due to the unavailability of LHRH for 
stimulation testing and given that most of our patients were prepubertal , only 9 patients 
had LHRH stimulation tests once they were pubertal. 
Gonadotrophin deficiency was defined as an inappropriately low FSH and LH responses 
following 2.5mcg/kg of GnRH given intravenously. 
Diabetes insipidus was defined on the basis of urine output of 2500ml/metre squared body 
surface area/day in infants and 1500ml/metre squared body surface area/day in children 
with urine osmolality < 300 mOsm/kg and serum osmolality >298m0sm/kg. 
The following information was obtained and presented in graph and table format. 
1. Age distribution. 
2. Presenting complaints. 
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3. Preoperative endocrine evaluation 
4. Number of Ventriculoperitoneal shunts and Omaya reservoirs. 
5. Surgical and radiotherapy options. 
6. Postoperative endocrine evaluation 
Heights and weights preoperatively and post operatively were inconsistently recorded and 
were therefore not used in the study although at followup all weights and heights are 
carefully plotted. 
LITERATURE REVIEW 
Similar studies have been conducted on a much more extensive basis internationally but 
the unique feature of this study is that there is no data within a South African context to 
highlight the extent of problems like growth hormone deficiency and the limited resources 
we have to provide growth hormone treatment to our patients. 
Therefore literature reviews were conducted to assess how we could improve our test 




The medical records of 45 children aged between 9 months and 13 years were reviewed. 
Our study comprised of 24 females and 21 males. The largest group of children diagnosed 
with craniopharyngiomas were aged between 5 and 10 years (Table 1) 
AGE DISTRIBUTION TOTAL NUMBER FEMALE MALE 
0 - 4 YEARS 12 7 5 
5 - 9YEARS 19 10 9 
10-15YEARS 14 7 7 
45 24 21 
Table 1 : Age and Gender distribution of children with craniopharyngiomas 




NUMBER OF PATIENTS 10 
5 
0 
0-4years 5-9 years 
AGE IN YEARS 
There was no significant gender predilection of craniopharyngiomas . 
PRESENTING SYMPTOMS: 
10-15 years 
Table 2 lists the presenting clinical features which were divided according to those due to 
raised intracranial pressure such as headache , vomiting and visual disturbances, 
symptoms related to anterior pituitary and posterior pituitary hormone deficiency and less 
difficult to define symptoms such as seizures and learning difficulties. 
Table 2 : Presenting symptoms 
SYMPTOMS INCIDENCE (number and percentage) 
N=45 





28 ( 62%) 
10 ( 22%) 
26 ( 57%) 
SYMPTOMS RELATED TO PITUITARY DYSFUNCTION: 
Polydipsia/polyuria 
Short stature 
NON SPECIFIC SYMPTOMS: 
Weakness/hemiparesis 
Seizures 
Loss of independence 
Ataxia 
Deteriorating school work 





Decreased level of consciousness 













Karavitaki et al (5) found that headaches and visual disturbances such as diplopia and even 
blindness were the commonest pressure related symptoms in children. 
Headaches occurred in 62% of the children as a presenting symptom and visual 
disturbances in 57 % of children which was detected either as presenting problem or on 
formal testing. 
The commonest visual field defect was that of a bitemporal hemianopia due to optic chiasm 
compression by the craniopharyngioma. 
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Stretching of the diaphragm sellae by the enlarging tumour is one of the most likely causes 
of the headache and could also be as a result of the obstruction of the aqueduct of 
Sylvius and the Foramen of Munro causing hydrocephalus (1). 
Growth hormone deficiency manifesting as short stature occurred in 31 % of children at 
presentation largely due to destruction of the anterior pituitary gland by the 
craniopharyngioma. Although the other causes of short stature have to be considered , 
in the context of craniopharyngiomas it is assumed that preoperatively prior to growth 
hormone stimulation tests to confirm the diagnosis, that growth delay is most likely due to 
growth hormone deficiency. 
Short stature was particularly a problem in the group where the diagnosis of the 
craniopharyngioma was delayed. 
Seizures also occurred commonly as a presenting symptom in 22% of the group which 
could be due to raised intracranial pressure or due to the expansile nature of the tumour 
acting as an epileptogenic focus. 
Most of the remaining presenting features were non specific and varied from fatigue and 
poor school performance to attention deficit hyperactivity disorder to account for 
regression in milestones and poor school performance. 
Hydrocephalus was found in 23 patients necessitating urgent surgical intervention and the 
insertion of ventriculo peritoneal shunts. 
DELAY IN DIAGNOSIS: 
The delay in the diagnosis of craniopharyngioma from the time of presentation to the time 
of diagnosis varied very widely. 
This time interval was ascertained from the history with regard to the duration of 
symptoms (particularly headaches ) until the time the diagnosis was made. 
On average there was a six month delay from presentation to diagnosis in most cases but 
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in 1 case there was a three year 8 month delay before the craniopharyngioma was 
diagnosed. 
The delay could be attributed to a number of factors including the failure to recognise 
subtle symptoms and signs of raised intracranial pressure and endocrine dysfunction as 
well as the lack of neuro- imaging techniques such as CT heads and MRI scans in rural 
areas. 
Inadequate growth monitoring particularly height measurements is also an 
important cause of the delay in diagnosis as a deterioration in growth velocity is probably 
the earliest sign of growth hormone deficiency. ( 6) 
PREOPERATIVE ENDOCRINE DYSFUNCTION 
Only 29 of the 45 children with craniopharyngiomas ( 64% ) had preoperative pituitary 
hormone evaluation and it is assumed that this is because the remaining children required 
emergency management of raised intracranial pressure and hydrocephalus and were too 
ill to conduct preoperative tests on them. Preoperative endocrine tests on children with 
craniopharyngiomas were not routinely done at either Red Cross Hospital or Groote 
Schuur Hospital prior to 1992. 






GH = growth hormone 
TSH = thyroid stimulating hormone 
ACTH = adrenocorticotrophin hormone 















GH ACTH TSH 
HORMONE DEFICIENCIES 
Figure 3 : Preoperative Pituitary Hormone Deficiencies 
D.I 
Unlike other studies (5) prolactin levels and FSH and LH levels were not measured in our 
patients . Hyperprolactinemia is largely due to pituitary stalk compression and with 
disruption of the hypothalamic pituitary axis and is more commonly associated with 
pituitary tumours in adults. Measuring prolactin levels in children with 
craniopharyngiomas is indicated to assess hypothalamic dysfunction and is an issue that 
should be addressed in the future. 
Preoperatively all children found to have secondary hypothyroidism were supplemented 
with thyroxine orally at 100 mcg / metre squared a day , cortisol was replaced with 
dexamethasone pre and intra operatively and was then converted to hydrocortisone 8-12 
mg/metre squared per day in 2 divided doses. 
Desmopressin was commenced in children with central diabetes insipidus at 0.05 - 0.1ml ( 
5 - lOmcg per dose) intra nasally. 
VENTRICULOPERITONEAL SHUNTS AND OMAYA RESERVOIRS: 
23 of our patients required ventriculoperitoneal shunts as emergency procedures in order 
to alleviate hydrocephalus. 
Fifteen children particularly those with large cystic components to their 
craniopharyngioma had intratumoral Omaya reservoirs inserted in the event that 
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aspiration of the cyst was necessary. as well as for intratumoral brachytherapy to shrink 
the cyst. 
NEURO IMAGING 
Most of the craniopharyngiomas were diagnosed by imaging of the brain and then 
confirmed histologically intra operatively. 
Table 4 : types of imaging techniques used 
Skull x ray 7 ( 15% ) 
CT head 31 ( 69%) 
MRI brain 9 ( 20 %) 
Unknown 5 ( 11 % ) 
Figure 4: 
MRI brain illustrating a craniopharyngioma 
TREATMENT MODALITIES 
Depending on the location of the tumour either intrasellar or suprasellar, the surgical 
approach and type of excision differs. 
Pterional craniotomy is the standard approach to suprasellar lesions as it allows good 
visualisation of the optic tracts. Where possible total removal of the tumour is attempted 
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with preservation of the optic chiasm and pituitary stalk. If a subtotal resection is only 
possible adjunctive radiotherapy is used. 
Table 5 : surgical modalities used to treat craniopharyngioma 
PROCEDURE 
Surgery only 
NUMBER OF PATIENTS 
13 ( 29%) 
Surgery and radiotherapy 13 ( 29% ) 
Intratumoral radiotherapy - yttrium 1 patient 
Bleomycin 6 patients 
No surgery 1 patient 
Inoperable 2 patients 
In our population the transsphenoidal approach has not yet been attempted because of a 
lack of expertise and the size of the intra sella lesions makes this approach technically 
difficult in children. One patient has not been operated on because of the 
craniopharyngioma being too small for resection and the absence of any signs of raised 
intracranial pressure or visual impairment. 
POST OPERATIVE PITUITARY HORMONE DEFICIENCY 
Significant morbidity and mortality is associated with craniopharyngioma surgery. 
There was no reversal of pre existing pituitary hormone deficiencies after surgical 
intervention. Instead there was a more significant deficit in pituitary hormone dysfunction. 
Table 6 : post operative endocrine dysfunction. 
HORMONAL DEFICIENCY 
panhypopituitarism 
GH and ACTH deficient only 
TSH deficiency only 
Diabetes insipidus only 
Normal 
NUMBER OF PATIENTS 
N=43 (100%) 
24 ( 56%) 
4 (9 % ) 
5(11%) 
4 ( 10%) 
6 (14%) 
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Figure 5 : Post operative Pituitary Hormone deficiencies 
POST OPERATIVE ENDOCRINOPATHIES 
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PANHYPO GH TSH D.I NORMAL 
HORMONE DEFICIENCIES 
Panhypo = ACTH/GH/fSH/FSH/LH deficiency and diabetes insipidus 
GH = growth hormone 
ACTH = adrenocorticotrophin hormone 
TSH = thyroid stimulating hormone 
D.I = diabetes insipidus 
SURVIVAL 
Number of deaths from 1976 to 2004 - 4 
Cause of death : 
1 due to recurrence of the craniopharyngioma with intralesional bleomycin extravasation 
1 due to recurrence with an irresectable tumour 
1 death due to severe hyponatremia and septic shock 
1 death due to irresectable tumour at presentation 
RECURRENCE OF CRANIOPHARYNGIOMA 
There were 13 recurrences documented in the patient study. However in 20 patients 
recurrences were not documented. 
BONE AGE: 
Xrays of the left wrist and hand were taken in order to assess the bone age . 
Bone age was scored according to Gruligh and Pyle guidelines. 
Only 24 of the 45 patients had bone ages done particularly in the last ten years of practice. 
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In all 24 children the bone age was delayed on average between 1 and 4 years. The delay 
was more obvious in those children who had panhypopituitarism at the time the bone age 
was done. 
HORMONAL REPLACEMENT THERAPY 
Children who had panhypopituitarism post operatively were routinely commenced on 
Eltroxin 
Desmopressin (ODA VP) 
Hydrocortisone 
1 OOmcg/metre squared daily 
5 - 10 mcg per dose intranasally 
8-12 mg/metre squared 
Testosterone or oestrogen supplementation to induce puberty 
Of the total of 24 children who had panhypopituitarism only 3 children are currently on 
growth hormone replacement therapy as they were privately funded but most children 
were unable to afford the treatment. Growth hormone replacement therapy in children 
with growth hormone deficiency has not only had the psychological benefits of improving 
linear growth but has also contributed to improving bone density and somatic growth. At 
present the inability to provide growth hormone to our patients is purely due to f"mancial 
constraints and given our results where 38% of our children were growth hormone 
deficient preoperatively and 63% post operatively it is imperative that these issues be 
addressed in the future. 
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DISCUSSION 
The study of endocrine dysfunction in children with craniopharyngiomas is not a unique 
study but the study in the context of a South African experience is, as it provided us with 
a useful way to analyse local children with craniopharyngiomas. 
The limitations of this study being a folder review included : 
Incomplete data recorded at the time of diagnosis particularly investigations for 
endocrine dysfunction. 
Computer laboratory records only date back to 1995 therefore accessing old results was 
not possible. 
Children were seen initially at Red Cross Childrens Hospital preoperatively and then 
transferred to Groote Schuur Hospital for post operative endocrine evaluation as well as 
radiotherapy and there was a significant loss in the details of preoperative endocrine 
investigations and details of the admission at Red Cross Hospital. 
In most children with craniopharyngiomas, endocrine dysfunction is present long before 
the diagnosis of the tumour is established. 
After treatment with surgery and/or irradiation endocrine problems become a major cause 
of morbidity and mortality. 
AGE DISTRIBUTION 
The distribution of age at presentation of the craniopharyngioma is shown in table 1 and 
Figure 2. 
The largest group of children diagnosed with craniopharyngiomas were aged between 5 
and 10 years which is much younger than in other studies (3) where the age of 
presentation was 11 years. 
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Our youngest patient was aged nine months at diagnosis. 
There was no gender predilection of craniopharyngiomas. (Table 1) 
PRESENTATION 
The proximity to and subsequent pressure effects of craniopharyngiomas on the 
hypothalamus and pituitary, the visual pathways, the brain parenchyma and major blood 
vessels predispose patients to multiple clinical manifestations at the time of presentation. 
Neurological symptoms in children due to obstructive hydrocephalus and raised 
intracranial pressure are common in children whose cerebral tissue is particularly 
vulnerable. 
The most frequent presenting features in our patients were headache (62%), visual 
disturbances ( 57% ), short stature (31 % ), vomiting ( as a symptom of raised intracranial 
pressure) in 22% and seizures in 22% (Table 2 ). 
Similarly in larger studies , headaches and visual disturbances were the commonest 
presenting symptoms in children , between 50- 78% and 62 - 79% respectively.(20) 
The signs and symptoms associated with raised intracranial pressure were identified in a 
significantly higher number of children than adults , which is in keeping with other 
reports suggesting that these features may be the commonest presenting symptom in 
children and should not be ignored (11). 
Although previous studies have shown that only 7% of children with craniopharyngiomas 
present with short stature , in our study 31 % were found to be short on presentation and 
had subnormal growth rates. 
The majority of children who presented with seizures were diagnosed with 
craniopharyngioma following CT head as part of the investigation of the seizures. 
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Visual disturbances were a common presenting symptom and ranged from diplopia to 
complete blindness and visual field defects. The majority of children with 
craniopharyngiomas have bitemporal hemianopias but prolonged untreated raised 
intracranial pressure can cause optic atrophy and blindness. 
Headaches in children with craniopharyngiomas was largely a symptom of raised 
intracranial pressure but in some studies was thought to be due to the stretching of the 
diaphragm sella by the enlarging tumour (1,6). 
Among the hormone deficiencies growth hormone deficiency is the most common and is 
seen in approximately 75% of children with craniopharyngiomas(2). Growth failure or 
growth deceleration is a frequent cause for referral or investigation. ( 15). 
After surgical treatment of craniopharyngiomas up to 90% of children show growth 
deceleration. Sorva (4) reported that in his study 19 patients had growth failure 
preceding the diagnosis of the craniopharyngioma by a mean of 4 years. 
Similarly in the study population investigated here 31 % (14 patients) were referred for 
investigation of short stature preceding the diagnosis of the craniopharyngioma. 
Growth hormone secretion occurs in pulses and in between the pulses growth hormone 
levels may be undetectable therefore random growth hormone levels are of limited 
value. The diagnosis of growth hormone deficiency depends on provoking growth 
hormone secretion using physiological and pharmacological stimuli and if suspected 
should be tested pre operatively.(6) 
Growth hormone treatment is recommended to facilitate catch up growth in growth 
hormone deficient patients shown to be free of the tumour after treatment. However the 
consequences of growth hormone therapy in patients with residual tumours is unclear as 
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there has been concern about recurrence of the tumour on growth hormone treatment. 
Some centers begin growth hormone replacement within six months of surgery. 
Two large studies have shown no increase in the risk of tumour recurrence in children 
receiving growth hormone following surgical removal of the craniopharyngioma (3). 
The main problem facing the majority of children in developing countries including this 
patient population is the lack of funds to pay for human growth hormone replacement 
therapy and most of these children will not be priviledged enough to receive this 
treatment purely because of the lack of finances in the State services. 
30 
DELAY IN DIAGNOSIS 
There was a significant delay in the diagnosis of craniopharyngiomas in our study with a 
time interval ranging from six months to almost four years before the diagnosis of the 
craniopharyngioma was made in one case. 
Headaches ( as the most frequent presenting symptom in children ) should be taken 
seriously and children should at least have fundoscopy to exclude papilloedema and in 
cases where visual defects are evident a CT head is indicated urgently. 
It also appears that the delays in diagnosis occurred mainly in smaller towns outside of 
Cape Town where it is assumed that there is a lack of access to radiological facilities. 
This delay in diagnosis needs to be addressed in the future and ways to improve our 
diagnostic time needs to be investigated. 
In cases of less obvious symptoms such as poor school performance and fatigue as well 
as endocrine dysfunction, it is difficult to propose how to improve diagnostic tests in 
order to diagnose craniopharyngiomas in these children earlier. Here it is suggested that a 
high index of suspicion be maintained and that thorough physical examination with 
growth measurements be done on every child. 
PRE OPERATIVE ENDOCRINE DYSFUNCTION 
One of the aims of this study was to assess if endocrine dysfunction was present pre 
operatively in our patient cohort. 
De Vile (12) suggested that although symptoms attributable to endocrine dysfunction 
were uncommon as the presenting complaint the majority of patients had symptoms to 
suggest an endocrinopathy at diagnosis. 
The available data for pre operative endocrine status in children with craniopharyngiomas 
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suggest that hypothalamic pituitary dysfunction is present in 80-90% of subjects (7). 
In our study pre operative endocrine tests were incomplete as only 29 of the 45 children 
(64%) had had preoperative pituitary hormone investigations. 
Possible reasons for this include the fact that on admission children with newly diagnosed 
craniopharyngiomas were admitted by the neurosurgical team before the endocrinologists 
were aware of the patients and the opportunity to do pre operative tests were missed. 
Further more since hydrocephalus and raised intracranial pressure is a common 
presenting feature in children, it is likely that these children were taken to theatre for 
emergency ventriculo peritoneal shunts and were too ill to conduct any blood tests on. 
All children with craniopharyngiomas are however commenced on dexamethasone 
preoperatively and post operatively are monitored closely for central diabetes insipidus. 
The incidence of other pituitary hormone deficits before surgery has been documented as 
75% for growth hormone deficiency (GH) 
25% for thyroid stimulating hormone (TSH) and adrenocorticotrophin hormone (ACTH) 
deficiency 
9-17% for anti diuretic hormone deficiency (ADH) 
40% for gonadotrophin hormone (GnRH) deficiency (5) 
Our study shows a higher incidence of ACTH and TSH deficiency rather than GH 
deficiency but this is most likely because most children have routine thyroid function 
tests, serum osmolality and electrolytes preoperatively and are not subjected to 
provocative growth hormone testing prior to surgery .. 
Halac (6) suggests that IGFl and IGF binding protein 3 (IGF BP3) assays be done in 
conjunction with a bone age and if the bone age was delayed with both IGF-1 and IGF-
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BP3 levels low then the patient was growth hormone deficient and did not require 
provocative tests to prove growth hormone deficiency. 
If the IGFl was normal then growth hormone stimulation tests were indicated. 
Most of our patients were prepubertal at the time of diagnosis and did not have LHRH 
stimulation tests preoperatively. 
ACTH deficient children were treated with hydrocortisone at 8-12mg / metre squared per 
day in two divided doses with the bigger dose being taken in the morning. 
ACTH deficiency may be very subtle but at times of stress can lead to hypotension and 
death. A diagnosis of ACTH deficiency can be made by finding sub normal cortisol 
levels and low ACTH levels. 
ACTH deficiency was reported in 25-71 % of children with craniopharyngiomas pre 
operatively (4). 
Thyroxine replacement was commenced on children with secondary hypothyroidism who 
had a low TSH with a low free thyroid hormone level (FT4). 
At diagnosis 10% of our patients had ADH deficiency which has been found to be 
present in up to 38% of children with craniopharyngiomas at the time of diagnosis(6). 
Evaluation of the fluid and electrolyte status of craniopharyngioma patients is important 
since appropriate treatment of diabetes insipidus can minimize morbidity and mortality. 
Determination of urine specific gravity, urine and serum osmolality and serum 
electrolytes is part of the initial laboratory workup. 
The diagnosis of central diabetes insipidus is confirmed by the inability to concentrate 
urine despite elevation of plasma osmolality and is easily treated. 
The most common presenting symptom of craniopharyngiomas in adults is 
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gonadotrophin deficiency. Most of our patients are pre pubertal therefore FSH and LH 
levels are not routinely measured. Levels of oestradiol in girls and testosterone in boys 
are within the pre pubertal range and these patients are commenced on hormonal 
replacement treatment at an appropriate age for pubertal development. 
PROLACTIN 
Increased prolactin levels were noted in 8-50% of children with craniopharyngiomas pre 
operatively (4). 
Hyperprolactinemia results from disturbed secretion the prolactin inhibiting factor due to 
hypothalamic damage. 
Prolactin levels are not measured routinely in our patients and will be proposed as a 
recommended test of hypothalamic function in the future (see conclusion and proposals). 
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VP SHUNTS AND OMAYA RESERVOIRS 
The ideal approach to a craniopharyngioma is a total resection, owing to the fact that a 
partial resection will later lead to a recurrence. However because a total excision is not 
always possible and often results in major deficits such as hypothalamic dysfunction a 
palliative procedure in combination with radiotherapy or chemotherapy is preferred. 
Unilateral or bilateral VP shunts were required in 23 of our patients (54%) as emergency 
procedures to alleviate hydrocephalus. 
In 1985 Takahashi demonstrated a reduction in the cystic portion of the 
craniopharyngioma after direct injection ofbleomycin into the cyst (34). 
The rationale for intramural bleomycin injection as an adjuvant therapy for 
craniopharyngiomas are because most tumours are associated with a cyst, it is an 
epithelial tumour and although ideally treatment of a craniopharyngioma is a complete 
excision, total excision is not possible in many cases especially where the tumour is 
located adjacent to vital structures. 
In our study , 6 of our patients received intratumoral bleomycin particularly in children 
who had had a recurrence or were too young for external beam irradiation. Bleomycin 
acts by inhibiting DNA synthesis and also inhibits the synthesis of proteins.(31) It was 
found to decrease secretion of cystic fluid and cause tumour cells to degenerate.(31) 
Intratumoral bleomycin is recommended when total excision of a cystic 
craniopharyngioma is not possible especially in young patients. 
The treatment of craniopharyngiomas remains controversial which reflects the 
heterogeneity of these tumours and the difficulty in management. Total tumour excision 
yields the best outcome but this is not always possible. There are several operative 
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approaches which take into account visual field defects and lateralisation of the mass. 
29% of our patients had surgery only with a near total excision of the craniopharyngioma. 
In a further 29% , only subtotal resections were possible and these children then have had 
adjuvant radiotherapy. 
Despite its benign nature craniopharyngiomas often cause neurological and 
endocrinological impairment. Most neurosurgeons believe that total excision is the only 
reliable approach to prevent recurrence. However even after total resection, the 
recurrence rate is still high and the severity of endocrine dysfunction tends to correlate 
with the extent of the resection. 
Radiotherapy may be effective in preventing the recurrence of the tumour when total 
resection is not possible. However because of the location of the craniopharyngioma 
adjacent to the hypothalamus and pituitary gland, radiotherapy should be considered 
carefully especially in young children. 
One of the study patients had a small intrasellar craniopharyngioma which has not 
caused any pressure effects or visual deterioration and has therefore not been operated on 
yet. Transsphenoidal resection of the tumour would be ideal in this patient but due to 
technical difficulties such as the size of the sella turcica being too small in children, this 
procedure was not undertaken. 
POST OPERATIVE HORMONE DEFICIENCY 
Recovery of pre operative deficits following craniopharyngioma surgery is rare. Damage 
to the hypothalamic pituitary system exerted by the hydrocephalus or the tumour itself is 
permanent. In this series as well as in other reports ( 1,2,4, 11,34) craniopharyngiomas 
were associated with a high rate of long term endocrine morbidity. 
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The deterioration of endocrinological function may be attributed to the damage by the 
tumour and its recurrences, the surgical interventions as well as the effects of 
radiotherapy. 
The majority of the study patients (56%) had panhypopituitarism post operatively 
reflecting both anterior and posterior pituitary damage. 
Interestingly enough 13% of patients had no pituitary hormone deficits in the short term 
and these were the children that had had surgery only without radiotherapy. 
This further supports the theory that the surgical approach used can greatly influence the 
severity of endocrine dysfunction. In some studies it has been suggested that the 
transsphenoidal approach is the best approach to preserve pituitary function (5). 
The attempt to preserve the pituitary stalk is a time consuming process but is rewarded 
with improved endocrinological results. It has been reported in the literature that the 
degree of post op endocrine deficiency depends on the extent of the tumour removal (5). 
This study did not specifically look at which groups of children had endocrine 
dysfunction in relation to the type of surgical approach they had been subjected to as it 
would help explain the variability in endocrine dysfunction from panhypopituitarism to 
normal pituitary function. 
External beam radiotherapy carries a high risk of delayed endocrine deficiency of anterior 
pituitary functions and endocrinological function gradually deteriorates over time. The 
effect depends on the radiation dose and because of the delayed onset of endocrine 
dysfunction all children who have had radiotherapy need to be monitored for growth 
deceleration, hypothyroidism and cortisol deficiency. 
The rate of diabetes insipidus is high post surgery and in some children tends to be 
transient. 
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Sixty five percent of the study patients had diabetes insipidus post surgery which is 
similar to other studies (5). 
In this series the unique phenomenon of growth without growth hormone has also been 
documented in two of our patients. 
Excessive weight gain is one of the most distressing manifestations of hypothalamic 
injury following craniopharyngioma surgery and has been thought to be the reason for 
growth despite being growth hormone deficient. 
Two distinct mechanisms (30) of hypothalamic obesity are now recognized. Injury to the 
ventromedial nuclei results in a complex of autonomic disturbances whereby increased 
parasympathetic and reduced sympathetic activity lead to hyperinsulinemia and 
decreased thermogenesis. The second mechanism involves injury to the paraventricular 
nuclei whereby hyperphagia is a direct result and is a sufficient cause of excessive 
growth. 
Rapid weight gain is a sensitive indicator of hypothalamic dysfunction and makes 
surgical decisions to avoid further hypothalamic damage of paramount importance. 
Figure 7 : MRI image of craniopharyngioma 
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NEUROIMAGING 
The rationale behind imaging of the brain is to define as accurately as is possible the 
altered geography and peculiar character of complex neoplasms. 
The imaging of craniopharyngiomas may include skull xrays, computerized tomography 
(CT) scans or magnetic resonance imaging scans (MRI) to define regional anatomy. 
Although only 15% of the study patients had skull xrays , a skull xray provides the most 
accurate depiction of the sella and calcification associated with craniopharyngiomas. 
The majority of patients (69%) had CT scans and in some cases both CT heads and MRI 
brains were done to define the lesion. Contrast CT scan will enhance the solid portion 
of the tumour and often the cyst capsule as well. 
MRI is best done to define the brain- mass interface. 
Neuro imaging provides an excellent road map if done correctly. Without adequate 
preoperative imaging , neurosurgical intervention is compromised. Where possible an 
MRI of the brain should be done as well. 
SURVIVAL 
Craniopharyngiomas are associated with decreased survival (3,5,6, 13, 18) . The long term 
morbidity of craniopharyngiomas is associated with damage to critical neuronal 
structures by the primary or recurrent tumour and/or with the adverse effects of the 
therapeutic interventions. The assessment of the treatment option with the least long term 
morbidity is difficult as recurrences and subsequent therapeutic interventions contribute 
to the final outcome. 
The overall survival rate for our patient population is 91 % which correlates with other 
bigger studies as well.(5) 
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Karavitaki et al ( 5) demonstrates an overall cumulative probability of survival of 91 % at 
5 years and 90% at 10 years following diagnosis. Ten year survival rates were better 
after complete removal of the tumour and in the group that had had a partial removal of 
the tumour followed by radiotherapy. 
An accidental extravasation of bleomycin in one of our children underlines the potential 
hazards of intratumoral chemotherapy. 
The study demonstrated a favourable outcome despite recurrences with only one death 
attributable to tumour recurrence. 
Long term morbidity of craniopharyngiomas is associated with damage to critical 
neuronal structures by the primary or recurrent tumour. 
Inadequate data in the bedletters precluded the collection of data regarding 
neuropsychiatric and neurocognitive evaluation .. 
Karavitaki (5) also showed that a significant number of patients had permanent motor 
deficits, epilepsy, and psychological disorders necessitating treatment .Although there is 
no doubt that cognitive impairment occurs in the developing brain, the modem 
techniques with reduction of the volume of the exposed normal tissue and optimizing the 
irradiation dose has contributed to minimizing neurocognitive deficits. 
Another component of this study which we were unable to complete is that of the 
comparison of premorbid weights with post operative weight gain as a reflection of 
hyperphagia and the severity of hypothalamic dysfunction. 
The importance of this must be emphasized especially with regard to the possibility of 
developing type 2 diabetes and insulin resistance associated with obesity as well as 
hyperlipidemias and the devastating consequences thereof. 
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Pereira (10) in a study at Leiden University also confirmed the long term adverse 
cardiovascular, neurological and psychosocial morbidity after treatment of a 
craniopharyngioma .. As shown in this study , survival post craniopharyngioma treatment 
is favourable but the long term prevalence ofhypopituitarism was high (89%) and the 
long term sequelae of cardiovascular complications needs to be closely screened for 
especially in post pubertal individuals where oestrogen replacement in females especially 
needs to be actively implemented. 
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CONCLUSION 
Within the constraints of a retrospective folder audit , the presenting symptoms and 
preoperative and post operative pituitary hormone deficits in 45 children diagnosed with 
craniopharyngiomas from 1976 to November 2004 were assessed. Although this 
information is widely available in large international studies, it is important that the 
the morbidity associated with craniopharyngiomas in children in an African context 
where access to MRI scans is limited and treatment options curtailed by financial 
constraints, was documented. 
The shortcomings of this study include the fact that being a retrospective folder audit 
access to information was limited by incomplete notes as well as the fact that most 
patients were diagnosed at Red Cross Children's Hospital and then transferred to Groote 
Schuur Hospital for endocrine workup or radiotherapy with incomplete notes and 
inadequate referral letters. 
The endocrine team prior to 2000 were not timeously informed of the patients and the 
opportunity to conduct preoperative tests was lost. Moreover the laboratory computer 
systems since 2001 have been upgraded and all old laboratory results prior to this time 
are not accessible thereby making it difficult to check up on old data and laboratory 
results. 
Various pharmacological agents can influence the tests conducted to assess growth 
hormone and adrenocorticotrophin hormone. The use of high dose glucocorticoid steroids 
can cause generalized suppression of growth hormone, ACTH, thyroid hormone and 
prolactin. Phenytoin and carbamazepine can also interfere with thyroid function and give 
falsely reduced levels of TSH and thyroxine, particularly when anti epileptic agents are 
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used to treat seizures at presentation. 
The interpretation of our test results needs to take these factors into consideration. 
Adrenal insufficiency may mask the signs and symptoms of central diabetes insipidus. 
The absence of glucocorticoids can ameliorate polyuria and increase urine osmolality of 
patients with untreated diabetes insipidus.Therefore all test results need to be interpreted 
in the context of the patient and the medication they are receiving. 
This study confirmed the widely accepted view that craniopharygiomas although benign 
in histological appearance are often associated with unfavourable and occasionally 
deleterious sequelae. 
It also showed that presenting complaints in children usually relate to raised intracranial 
pressure effects but evidence of hypothalamic pituitary dysfunction, in particular short 
stature was often present at the time of diagnosis. 
Preoperative endocrine evaluation although not always complete has been routine 
practice in the last 5 years. 
Compared to other studies the majority of our patients were aged between 5 - 10 years. 
Of major concern is that the delay in diagnosis of the craniopharyngioma was significant 
and in order to prevent this from occurring all health care practitioners in the clinics or in 
general practice are urged to take a detailed history particularly with regard to headaches 
and to plot weight and especially height at each visit as growth deficiency is probably the 
most subtle sign of growth hormone deficits. 
In this review, hypothyroidism and adrenal insufficiency secondary to ACTH deficiency 
followed by growth hormone deficiency were common at diagnosis. Features of diabetes 
insipidus were uncommon at diagnosis but very common post operatively. 
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The long term consequences of the craniopharyngioma and it's treatment although 
improved during the last two decades still remains bleak. 
Despite the fact that the majority of patients in this study had panhypopituitarism post 
operatively , only a minority received growth hormone treatment due to financial 
constraints. 
As indicated before growth hormone is not only required for linear growth but 
also assists in somatic growth and acquisition of bone matrix. Therefore the inability to 
provide this treatment has had significant consequences for our patients. 
Apart from the type of treatment, the identification of clinical and imaging parameters to 
provide prognostic indicators is also difficult and is an area that needs further 
investigation. 
The establishment of prognostic factors at a pathological level and the impact of new 
surgical approaches remains to be determined. 
Even if hormone levels are adequate in the short term, .after surgical resection or 




Following the review of our patient cohort the following recommendations have been 
suggested in order to optimize management of our children with craniopharyngiomas: 
1. Headaches and visual disturbances in children need to be investigated -
fundoscopy can be conducted at the initial examination-
2. Adequate growth monitoring with regular height measurements can indicate 
growth delay before the effects of raised intracranial pressure are manifest. Endo 
crinologists have an advocacy role to promote improved growth monitoring to 
facilitate early referral and diagnosis 
3. Essential preoperative endocrine evaluation includes testing for and treatment of 
ACTH adrenal insufficiency , assessment of salt and water balance and thyroid 
function 
4. Prolactin levels should be measured postoperatively as an indicator of the 
disruption of the hypothalamic pituitary axis 
5. Bone age xrays in combination with IGF -1 levels may help define the presence of 
growth hormone deficiency where growth hormone stimulation tests are 
contraindicated 
6. Post surgery and radiotherapy more extensive anterior and pituitary testing needs 
to be conducted including re evaluation of the ACTH adrenal axis, growth 
hormone release, thyroid functions and electrolytes and osmolality ideally in a 
controlled environment with the appropriate stimulation tests 
7. Regular followup at a multidisciplinary clinic to monitor for:-
• Recurrences of the craniopharyngioma 
• Visual deficits 
• Growth parameters including excessive weight gain as an indicator of 
hypothalamic damage 
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• Monitoring response to hormonal treatment especially hydrocortisone , 
thyroxine and DDAVP (desmopressin). 
• Implementing oestrogen and testosterone replacement therapy timeously 
• Bi annual lipid and glucose monitoring 
• Establishment of either a national growth hormone budget or acquisition 
of non governmental agencies to finance growth hormone replacement 
therapy 
• Comprehensive neuropsychiatric and cognitive followup for appropriate 
school placement 
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ALGORITHM FOR PRE OPERATIIVE EVALUATION 
OF CHILDREN WITH CRANIOPHARYNGIOMAS 
Height and weight measurement 
Ophthalmological assessment 
CT head / MRI brain 
Bone age 
Blood investigations : 8a.m cortisol 
TSH 





if normal then monitor post op and repeat 
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History to document diabetes insipidus, visual deterioration and raised intracranial 
pressure 
Height and weight measurement including body mass index and body surface area 
Anterior pituitary tests: TSH 
Metyrapone stimulation test 
Growth hormone stimulation test 
Prolactin 
Posterior pituitary tests urine and serum osmolality and electrolytes if indicated water 
deprivation test 
LONGTERM 
Height and weight at each visit 
Complete neurological examination 
Pubertal staging 
6 monthly thyroid function screen 
Annual ophthalmology screen 
Annual bone age xray 
6 monthly fasting lipid profile and glucose monitoring 
CT head / MRI brain with any suggestion of recurrence or if the craniopharyngioma was 
only partially resected 




Social worker for child dependency grant and emotional support 
Radiotherapy and neurosurgical input at least every 6 months or as problems arise (team 
work) 
FOR THE FUTURE 
Formulate a list of prognostic factors for craniopharyngiomas based on the Red Cross 
experience such as : 
Age at diagnosis 
Histology 
Size of the tumour and involvement of adjacent neural structures 
Preoperative endocrine deficits 
Type of surgical intervention 
Post operative endocrine deficits 
Severity of neuropsychiatric deficits 
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